Canada Pharmaceuticals & Biotech Potentially Undervalued Companies

Flower One Holdings Inc., through its subsidiaries, cultivates and produces cannabis for the recreational and medical cannabis markets in Nevada.

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases, and their symptoms in Canada, Europe, the United States, Asia, and internationally.

Delta 9 Cannabis Inc. operates as an integrated cannabis company.

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical marijuana company.

Biome Grow Inc., through its subsidiaries, operates as a licensed producer of cannabis in Nova Scotia under Canada’s ACMPR.

Westleaf Inc. engages in the cultivation, extraction, distribution, and sale of cannabis and cannabis related products.

Willow Biosciences Inc. engages in the biosynthetic production of plant-derived compounds.

CannTrust Holdings Inc. produces and distributes medical and recreational cannabis in Canada.

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

Captor Capital Corp. operates as a vertically integrated cannabis company in the United States.

48North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada.

BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells various pharmaceutical and other healthcare products in Canada and internationally.

Auxly Cannabis Group Inc. operates as an integrated cannabis company.

Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada.

Aphria Inc. produces and sells medical cannabis in Canada and internationally.

Aurora Cannabis Inc. produces and distributes medical cannabis products.